These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3441329)

  • 1. Radiopharmaceuticals and the Medicines Act.
    Turner JL
    Nucl Med Commun; 1987 Nov; 8(11):941-3. PubMed ID: 3441329
    [No Abstract]   [Full Text] [Related]  

  • 2. The medicines act and "me-too" drugs.
    Drug Ther Bull; 1976 Aug; 14(17):65-6. PubMed ID: 964134
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicines regulation in the United Kingdom.
    Watt AH
    Health Bull (Edinb); 1990 Sep; 48(5):219-24. PubMed ID: 2243015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Licensing and provision of medicines in the United Kingdom. An appraisal.
    Collier J
    Lancet; 1985 Aug; 2(8451):377-81. PubMed ID: 2862524
    [No Abstract]   [Full Text] [Related]  

  • 5. Return of the radionuclide shortage.
    Knight N
    J Nucl Med; 2009 Jul; 50(7):13N-14N. PubMed ID: 19652219
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical licensure in the United States and the United Kingdom.
    WATERHOUSE R
    Fed Bull; 1962 Jun; 49():156-9. PubMed ID: 14005224
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding patient needs: congressmen aid nuclear medicine.
    Kotz D
    J Nucl Med; 1998 Nov; 39(11):16N, 21N-22N, 30N. PubMed ID: 9829563
    [No Abstract]   [Full Text] [Related]  

  • 8. Redefining the role of the Veterinary Medicines Directorate.
    Rutter M
    Vet Rec; 1990 Apr; 126(16):373-4. PubMed ID: 2368260
    [No Abstract]   [Full Text] [Related]  

  • 9. Isotope availability task group releases draft report.
    Cannon H
    J Nucl Med; 2008 Aug; 49(8):38N. PubMed ID: 18672470
    [No Abstract]   [Full Text] [Related]  

  • 10. EMEA (European Medicines Evaluation Agency) and the new pharmaceutical procedures for Europe.
    Jones K; Jefferys D
    Health Trends; 1994; 26(1):10-3. PubMed ID: 10171959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing the unmanageable.
    Atcher RW
    Lancet Oncol; 2009 Aug; 10(8):745-6. PubMed ID: 19647197
    [No Abstract]   [Full Text] [Related]  

  • 12. Making optimal use of available molybdenum-99.
    Ballinger JR
    Nucl Med Commun; 2010 Oct; 31(10):841-3. PubMed ID: 20805729
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary: supplies of molybdenum-99--need for sustainable strategies and enhanced international cooperation.
    Ramamoorthy N
    Nucl Med Commun; 2009 Dec; 30(12):899-905. PubMed ID: 19904088
    [No Abstract]   [Full Text] [Related]  

  • 14. The review of medicines in the United Kingdom.
    Winship K; Hepburn D; Lawson DH
    Br J Clin Pharmacol; 1992 Jun; 33(6):583-7. PubMed ID: 1389930
    [No Abstract]   [Full Text] [Related]  

  • 15. IAEA addresses global radioisotope shortage.
    International Atomic Energy Agency
    J Nucl Med; 2009 Jan; 50(1):15N. PubMed ID: 19139182
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical isotope shortages.
    Somberg JC
    Am J Ther; 2009; 16(5):378. PubMed ID: 19955856
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiopharmaceutical issues.
    Silberstein EB
    J Nucl Med; 2002 Jan; 43(1):19N-20N. PubMed ID: 11820208
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiology now. Radiopharmaceuticals and the Medicines Act.
    Taylor DM
    Br J Radiol; 1974 Nov; 47(563):741. PubMed ID: 4433996
    [No Abstract]   [Full Text] [Related]  

  • 19. 186Re and high-specific-activity 177Lu available in North America.
    J Nucl Med; 2004 Apr; 45(4):22N. PubMed ID: 15073239
    [No Abstract]   [Full Text] [Related]  

  • 20. Government officials urge nuclear physicians to be more active in political process.
    Kotz D
    J Nucl Med; 1999 May; 40(5):13N, 15N, 31N. PubMed ID: 10319737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.